相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice
Eliot J. Davidowitz et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau
Matthias Brendel et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Antileukotriene therapy by reducing tau phosphorylation improves synaptic integrity and cognition of P301S transgenic mice
Phillip F. Giannopoulos et al.
AGING CELL (2018)
Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls (vol 64, pg S555, 2018)
Einar M. Sigurdsson
JOURNAL OF ALZHEIMERS DISEASE (2018)
Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy
Erin E. Congdon et al.
MOLECULAR NEURODEGENERATION (2016)
IMPAIRED BURROWING IS THE MOST PROMINENT BEHAVIORAL DEFICIT OF AGING HTAU MICE
Philippine Camilla Geiszler et al.
NEUROSCIENCE (2016)
Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology
Nicole Maphis et al.
ALZHEIMERS RESEARCH & THERAPY (2016)
Passive Immunization with Phospho-Tau Antibodies Reduces Tau Pathology and Functional Deficits in Two Distinct Mouse Tauopathy Models
Sethu Sankaranarayanan et al.
PLOS ONE (2015)
Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review
Allal Boutajangout et al.
GERONTOLOGY (2014)
Methods for Measuring Tau Pathology in Transgenic Mouse Models
Stefanie K. Forest et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Curcumin Suppresses Soluble Tau Dimers and Corrects Molecular Chaperone, Synaptic, and Behavioral Deficits in Aged Human Tau Transgenic Mice
Qiu-Lan Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models
Christopher M. Acker et al.
NEUROBIOLOGY OF AGING (2013)
Elevated Levels of Soluble Total and Hyperphosphorylated Tau Result in Early Behavioral Deficits and Distinct Changes in Brain Pathology in a New Tau Transgenic Mouse Model
S. Flunkert et al.
NEURODEGENERATIVE DISEASES (2013)
Anti-Inflammatory Impact of Minocycline in a Mouse Model of Tauopathy
Claire J. Garwood et al.
Frontiers in Psychiatry (2010)
Age-Dependent Impairment of Cognitive and Synaptic Function in the htau Mouse Model of Tau Pathology
Manuela Polydoro et al.
JOURNAL OF NEUROSCIENCE (2009)
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
C Andorfer et al.
JOURNAL OF NEUROSCIENCE (2005)
Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes
K Duff et al.
NEUROBIOLOGY OF DISEASE (2000)
分享论文
